New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
14:32 EDTZGNXZogenix surges after FDA approves pain management drug
Shares of Zogenix (ZGNX) are jumping after the company announced that the FDA had approved its pain management drug. WHAT'S NEW: The FDA announced intraday that it approved Zogenix's pain management drug, Zohydro. The agency approved the drug for use by patients who have pain severe enough to require daily, around-the-clock, long-term treatment and who cannot be adequately comforted with other treatment options, the company stated. WHAT'S NOTABLE: In a note to investors on September 27, William Blair analyst Tim Lugo wrote that his price target for Zogenix would have been about $6 if the FDA was to approve Zohydro. According to Lugo, Zogenix had several upcoming catalysts other than Zohydro that could enable the stock to outperform through September 2014. He kept an Outperform rating on the shares. TODAY'S PRICE ACTION: In mid-afternoon trading, Zogenix surged 93c, or 40%, to $3.15.
News For ZGNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
08:35 EDTZGNXZogenix submits modified formulation of Zohydro ER for FDA review
Subscribe for More Information
September 18, 2014
16:27 EDTZGNXZogenix gets exclusive licensing for Zohydro ER from Daravita
Subscribe for More Information
08:40 EDTZGNXZogenix reports new data shows Zohydro ER reduced pain, improved function
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use